Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Name: Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492
Published: 2014
License: Public Domain

Novartis Pharmaceuticals · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

adrenocortical adenoma, endometrial stromal sarcomas, adrenocortical adenoma,, bgg492, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492

Related documents